Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002902
Status:
COMPLETED
Last Update Posted:
2019-03-13
First Post:
1999-11-01
Brief Title:
Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Abramson Cancer Center at Penn Medicine
Organization Data
Organization:
Abramson Cancer Center at Penn Medicine
Class:
OTHER
Study ID:
CDR0000065242
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |